Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Hyrimoz“
Suchtreffer
Begriffe & Kennungen
Hyrimoz · 4.8 · 82 (maximum of 160 mg) at Week 0, placebo at Week 1, and 1.2 mg/kg (maximum of 80 mg) at Week 2 (N=30), ALT el
Eintrag öffnenHyrimoz · 4.8 · Adalimumab was studied in 9 506 patients in pivotal controlled and open label studies for up to 60 months or m
Eintrag öffnenHyrimoz · 4.8 · Adalimumab was studied in 9 506 patients in pivotal controlled and open label studies for up to 60 months or m
Eintrag öffnenHyrimoz · 4.8 · Blood and the Very common Leucopaenia (including neutropaenia and lymphatic system agranulocytosis), disorders
Eintrag öffnenHyrimoz · 4.8 · Blood and the Very common Leucopaenia (including neutropaenia and lymphatic system agranulocytosis), disorders
Eintrag öffnenHyrimoz · 4.8 · Cardiac disorders* Common Tachycardia
Eintrag öffnenHyrimoz · 4.8 · Cardiac disorders* Common Tachycardia
Eintrag öffnenHyrimoz · 4.8 · Common GI haemorrhage, dyspepsia, gastroesophageal reflux disease, sicca syndrome
Eintrag öffnenHyrimoz · 4.8 · Common GI haemorrhage, dyspepsia, gastroesophageal reflux disease, sicca syndrome
Eintrag öffnenHyrimoz · 4.8 · Common Leucocytosis, thrombocytopaenia
Eintrag öffnenHyrimoz · 4.8 · Common Leucocytosis, thrombocytopaenia
Eintrag öffnenHyrimoz · 4.8 · Common Systemic infections (including sepsis, candidiasis and influenza), intestinal infections (including gas
Eintrag öffnenHyrimoz · 4.8 · Common Systemic infections (including sepsis, candidiasis and influenza), intestinal infections (including gas
Eintrag öffnenHyrimoz · 4.8 · Concurrent treatment with azathioprine/6-mercaptopurine
Eintrag öffnenHyrimoz · 4.8 · Concurrent treatment with azathioprine/6-mercaptopurine
Eintrag öffnenHyrimoz · 4.8 · Description of selected adverse reactions
Eintrag öffnenHyrimoz · 4.8 · Description of selected adverse reactions
Eintrag öffnenHyrimoz · 4.8 · During the controlled portions of pivotal adalimumab studies in adults of at least 12 weeks in duration in pat
Eintrag öffnenHyrimoz · 4.8 · During the controlled portions of pivotal adalimumab studies in adults of at least 12 weeks in duration in pat
Eintrag öffnenHyrimoz · 4.8 · Ear and labyrinth Common Vertigo disorders Uncommon Deafness, tinnitus
Eintrag öffnen